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Doseeresponse effects of exercise
training on the subjective sleep quality
of postmenopausal women: exploratory
analyses of a randomised controlled trial
Christopher E Kline,1 Xuemei Sui,2 Martica H Hall,1 Shawn D Youngstedt,2,3,4
Steven N Blair,2,5 Conrad P Earnest,6 Timothy S Church7
ABSTRACT
Objective: To investigate whether a doseeresponse
relationship existed between exercise and subjective
sleep quality in postmenopausal women. This objective
represents a post hoc assessment that was not
previously considered.
Design: Parallel-group randomised controlled trial.
Setting: Clinical exercise physiology laboratory in
Dallas, Texas.
Participants: 437 sedentary overweight/obese
postmenopausal women.
Intervention: Participants were randomised to one
of four treatments, each of 6 months of duration: a non-
exercise control treatment (n¼92) or one of three
dosages of moderate-intensity exercise (50% of
VO2peak), designed to meet 50% (n¼151), 100%
(n¼99) or 150% (n¼95) of the National Institutes of
Health Consensus Development Panel physical activity
recommendations. Exercise dosages were structured to
elicit energy expenditures of 4, 8 or 12 kilocalories per
kilogram of body weight per week (KKW), respectively.
Analyses were intent to treat.
Primary outcome measures: Continuous scores
and odds of having significant sleep disturbance, as
assessed by the Sleep Problems Index from the 6-item
Medical Outcomes Study Sleep Scale. Outcome
assessors were blinded to participant randomisation
assignment.
Results: Change in the Medical Outcomes Study Sleep
Problems Index score at 6 months significantly
differed by treatment group (control: 2.09 (95% CI
4.58 to 0.40), 4 KKW: 3.93 (5.87 to 1.99),
8 KKW: 4.06 (6.45 to 1.67), 12 KKW: 6.22
(8.68 to 3.77); p¼0.04), with a significant
doseeresponse trend observed (p¼0.02). Exercise
training participants had lower odds of having
significant sleep disturbance at postintervention
compared with control (4 KKW: OR 0.37 (95% CI 0.19
to 0.73), 8 KKW: 0.36 (0.17 to 0.77), 12 KKW: 0.34
(0.16 to 0.72)). The magnitude of weight loss did not
differ between treatment conditions. Improvements in
sleep quality were not related to changes in body
weight, resting parasympathetic control or
cardiorespiratory fitness.
Conclusion: Exercise training induced significant
improvement in subjective sleep quality in
postmenopausal women, with even a low dose of
exercise resulting in greatly reduced odds of having
significant sleep disturbance.
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identifier: NCT00011193.
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ARTICLE SUMMARY
Article focus
- Sleep disturbance is prevalent in postmeno-
pausal women, with 35%e60% reporting
significant sleep problems.
- Effective, safe and easily available treatment
options for disturbed sleep in postmenopausal
women are lacking.
- There has been equivocal evidence as to whether
exercise improves sleep in postmenopausal
women, though possible doseeresponse
effects have been noted.
Key messages
- Exercise resulted in significant improvement in
subjective sleep quality in postmenopausal
women, with reduced odds of having sleep
disturbance at postintervention with even 50%
of the recommended dose of exercise for adults.
- The effects of exercise on sleep quality were
independent of changes in body weight, resting
parasympathetic control or cardiorespiratory
fitness.
Strengths and limitations of this study
- The study constitutes the largest randomised
controlled trial on exercise and sleep
quality, using a structured dose of exercise and
a validated measure of sleep quality.
- Only self-reported sleep was assessed; objective
measurement of sleep, with either actigraphy or
polysomnography, was not conducted.
- Despite the high prevalence of sleep disturbance
in the sample, participants were not selected on
the basis of sleep complaints.
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INTRODUCTION
Disturbed sleep is a common complaint among women,
with increasing prevalence beginning at the menopausal
transition. Postmenopausal women are more likely to
report sleep problems than premenopausal or peri-
menopausal women,1 with 35%e60% of post-
menopausal women reporting significant sleep
problems.2 The first-line treatment options for sleep
complaints, hypnotic medication and cognitive behav-
ioural therapy have associated concerns about the safety
of long-term use or treatment availability, respectively.3 4
Furthermore, results are conflicting on the effect
of hormone replacement therapy (HRT) on sleep
quality,5 6 despite the effectiveness of HRT at reducing
other menopausal symptoms.
A non-pharmacological treatment that has been
traditionally thought to improve sleep is exercise. In
epidemiological research, exercise has frequently been
associated with better sleep.7 However, experimental
research has provided less compelling evidence,8
particularly when regarding postmenopausal women. Of
the four randomised trials that have investigated the
effect of exercise on sleep quality in this population,9e12
only one reported a significant improvement in subjec-
tive sleep quality following an exercise intervention.12
However, despite the generally negative findings from
these studies involving postmenopausal women, possible
doseeresponse effects of exercise on sleep quality were
noted. In one of these studies, women who performed at
least 225 min of morning exercise per week had less
trouble falling asleep compared with those who exer-
cised <180 min per week in the morning.9 Likewise,
another study reported a positive association between
walking frequency and improvements in sleep.11
To our knowledge, no research has directly investi-
gated the effects of different doses of exercise on sleep
quality. The DoseeResponse to Exercise in post-
menopausal Women (DREW) trial was conducted to
investigate the health effects of 50%, 100% and 150% of
the National Institutes of Health (NIH) Consensus
Development Panel physical activity recommendations
in a group of sedentary postmenopausal women.13
Results on the primary outcomes of the study, cardiore-
spiratory fitness and blood pressure, have already been
reported.14 Subjective sleep quality was also assessed in
this trial as an exploratory outcome, and the data
provided herein give the first systematic examination of
whether a doseeresponse relationship exists between
exercise and subjective sleep quality. It was hypothesised
that, in comparison to a non-exercise control group,
subjective sleep quality would improve with increasing
dosage of exercise.
METHODS
A complete description of the recruitment and
screening procedures has been published elsewhere.13
Briefly, the study was a randomised, controlled, multi-
arm, parallel-group trial in which the primary purpose
was to examine whether there were doseeresponse
effects on cardiorespiratory fitness and blood pressure
with incrementally increasing doses of energy expendi-
ture.13 14 The study was approved annually by the
Cooper Institute Institutional Review Board, and written
informed consent was obtained by all participants prior
to study involvement.
Participants
Participants were recruited from the Dallas, Texas,
metropolitan area from April 2001 to June 2005. Of 4545
women screened for eligibility, those who were aged
45e75 years, postmenopausal, sedentary (#20 min of
exercise on #2 days/week and <8000 steps/day, aver-
aged over 1 week), overweight or obese (body mass
index (BMI) of 25e43 kg/m2) and had normal to mildly
elevated resting blood pressure (systolic blood pressure
of 120e159 mm Hg and diastolic blood pressure
#99 mm Hg) were eligible to participate (figure 1).
Exclusion criteria included significant cardiovascular
disease, recent hospitalisation for mental illness or
significant symptoms of depression (score $10 on the
Center for Epidemiologic Studies Depression Scale) or
any other health condition that would contraindicate
participation in an exercise programme. Overall, 464
women were randomised to treatment, with baseline
sleep data available for 437 participants.
Randomisation and retention
Prior to randomisation, participants completed a 2-week
run-in period, in which participants received lifestyle
modification instruction over the course of six labora-
tory visits. The primary purpose of this run-in period was
to maximise retention and adherence to the subsequent
intervention. Participants were compensated for
completing baseline and postintervention assessments,
with additional compensation based on intervention
adherence.13
Allocation of participants to treatment conditions was
accomplished using a computer-generated random-
isation sequence, determined from randomly permuted
blocks of equal length with fixed numbers of treatment
allotments to balance treatment enrolments over time.
Allocation concealment was achieved by placing treat-
ment assignment letters into sequentially numbered
opaque envelopes sealed by the study statistician. At
the time of randomisation, envelopes were opened by
a staff member not affiliated with the randomisation
process.13
Participants were randomised to one of four treatment
conditions: a non-exercise control group, or one of three
exercise groups expending 4, 8 or 12 kilocalories per
kilogram of body weight per week (KKW). Energy
expenditure levels for the exercise groups were designed
to correspond with 50%, 100% and 150% of the
NIH Consensus Development Panel physical activity
recommendations, respectively.15
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Interventions
Women assigned to the exercise groups participated in
three to four training sessions/week for 6 months,
alternating between semirecumbent cycle ergometer
and treadmill exercise. Training sessions were conducted
in a supervised laboratory setting, and exercise dosage
was closely monitored for each session. Training inten-
sity was moderate, set at the heart rate associated with
50% of each woman’s VO2peak and continuously moni-
tored by heart rate telemetry. To determine the number
of calories that needed to be expended each week,
participants were weighed weekly and their weight was
multiplied by the exercise dosage.
Exercise dose was gradually increased to minimise
injury risk. All exercise training groups expended 4 KKW
during the first intervention week, with the 4 KKW group
continuing at that dose for 6 months. The 8 and 12 KKW
groups increased their energy expenditure by 1 KKW
until they reached their appointed exercise doses.
Blinding
Although participants could not be blinded to their
treatment, staff were separated into intervention and
assessment teams to ensure blinding of all assessment
staff to participant randomisation assignment. Partici-
pants were consistently reminded to refrain from
discussing their randomisation assignments with
outcome assessment staff.
Sleep measure
Subjective sleep quality was assessed with six items from
the Medical Outcomes Study (MOS) Sleep Scale.16 At
Figure 1 Participant screening and study flow. Of 4545 screened for participation, 464 postmenopausal women were randomised
to one of four treatments. Baseline Medical Outcomes Study (MOS) Sleep data were available for 437 participants; those who
discontinued the study or without follow-up MOS Sleep data had baseline data carried forward for analysis. BMI, body mass index;
KKW, kilocalories of energy expenditure per kilogram of body weight per week.
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baseline and postintervention, participants were asked to
respond based on their sleep during the previous
4 weeks. One question, which addressed the length of
time to fall asleep, was framed with five response options
ranging from 0 to 15 min to >60 min. For the remaining
five questions (ie, restless sleep, daytime drowsiness,
difficulty falling asleep, awakening from sleep and
experiencing difficulty returning to sleep, staying awake
during the day), participants were asked to respond on
a 5-point scale, ranging from ‘none of the time’ to ‘all of
the time’. Item responses were assigned scores using
conventional scoring rules, with higher scores indicating
a greater severity of sleep disturbance. A modified Sleep
Problems Index (SPI), using all six sleep items, provided
a measure of overall sleep quality.17 SPI scores >25 were
considered to indicate significant sleep disturbance, as
prior work using a 9-item SPI reported that a cutpoint of
>25 identified individuals who considered themselves to
have a sleep problem with a sensitivity of 86.2% and
specificity of 66.3%.17
Scores on the MOS Sleep Scale have been shown to
correlate with other MOS health items,16 differentiate
between those with and without chronic health condi-
tions17 and improve with treatment of chronic
health conditions.18 Normative values for the general
population have also been developed.17
Other measures
Baseline demographic and health characteristics were
assessed by completion of a comprehensive medical
history questionnaire. Height and weight were measured
with a calibrated stadiometer and electronic scale,
respectively. Diet was assessed before and following the
intervention using a semiquantitative food-frequency
questionnaire, whereas unsupervised physical activity was
monitored throughout the study with a pedometer
(Accusplit Eagle, Livermore, California).
Cardiorespiratory fitness (VO2peak) was assessed from
maximal exercise testing using a cycle ergometer
(Excalibur Sport, Lode Medical Technology, Groningen,
the Netherlands), as previously described.14 Testing was
performed twice at baseline and twice at post-
intervention, with values from each timepoint averaged.
Heart rate variability (HRV) was measured from the final
5 min of a 25-min resting assessment, as previously
described.19 The square root of the mean of the sum of
the squares of differences between adjacent ReR inter-
vals (rMSSD), a marker of parasympathetic activity,20 was
retained for analysis.
Statistical power
Sample size was originally based on having adequate
power to detect changes in the primary outcomes of the
overall study, VO2peak and blood pressure.
14 Additional
participants were allocated to the 4 KKW condition to
increase statistical power for detecting smaller antici-
pated fitness gains in this group. Because sleep was not
a primary outcome in the design of the original study,
there was no opportunity before data collection to
investigate sample size or power for this outcome vari-
able. Nevertheless, given the current enrolment, the
study had 84% power (assuming two-tailed a¼0.05) to
detect an effect size of 0.20 for MOS SPI score reduction.
Statistical analysis
Baseline sleep quality was compared against normative
data17 using a one-sample t-test. Continuous MOS SPI
values were examined across quartiles of BMI, para-
sympathetic tone (rMSSD) and cardiorespiratory fitness
(VO2peak) with analysis of covariance (ANCOVA),
controlling for age, BMI, sleep medication use and HRT
use. The likelihood of having significant sleep distur-
bance at baseline (ie, MOS SPI >25) was evaluated with
logistic regression across the same quartiles using the
same covariates.
Two primary outcomes were evaluated for the current
study: (1) change in continuous MOS SPI score across
treatment groups and (2) odds of having significant
sleep disturbance at postintervention across treatment
groups. Change in continuous MOS SPI scores across
groups was tested by ANCOVA, with adjustment for age,
BMI, sleep medication use, HRT use and baseline MOS
SPI values. All assumptions underlying the ANCOVA
models were checked and verified to be met. Individual
treatment groups were compared with the control group
with TukeyeKramer adjustment for multiple compari-
sons. An a level of 0.05 was used because it was our
a priori intention to compare only the separate treat-
ment groups with the control group. Doseeresponse
trends were analysed using least-squares regression of
MOS SPI change across groups. Logistic regression
examined the odds of having significant sleep distur-
bance at postintervention, following adjustment for age,
BMI, sleep medication and HRT use, and baseline sleep
disturbance (SPI >25, SPI #25). Unadjusted analyses
provided similar results to those with covariate control,
so only those results with full covariate adjustment were
reported.
Finally, to examine whether improved sleep quality was
significantly influenced by body weight, parasympathetic
tone or cardiorespiratory fitness, changes in weight,
rMSSD and VO2peak were added to the ANCOVA and
logistic regression analyses. Additionally, among
completed participants, changes in MOS SPI score were
evaluated across quartiles of change in body weight,
rMSSD and VO2peak following adjustment for age, treat-
ment, BMI, sleep medication use, HRT use and baseline
MOS SPI score.
Analyses were limited to participants with baseline
MOS Sleep data. Primary analyses were conducted using
the intent-to-treat principle; if postintervention data
were missing, baseline values were carried forward for
analysis. When analyses were restricted to only those
participants with baseline and postintervention MOS
Sleep data (n¼359), results were not substantively
changed; similarly, when missing postintervention data
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were imputed with mean values, results were unchanged.
Therefore, only intent-to-treat analyses were presented.
All analyses were performed using SAS V.9.2 (SAS Insti-
tute). All tests were two-tailed, with statistical significance
set at p#0.05.
RESULTS
Participant characteristics
A summary of participant characteristics is provided in
table 1. Mean age and BMI of the 437 participants were
57.366.5 years and 31.863.9 kg/m2, respectively.
Baseline MOS SPI values and prevalence of sleep
disturbance are provided in table 1. Of the 437 partici-
pants, 46% of the sample (n¼200) were considered to
have significant sleep disturbance at baseline, as defined
as MOS SPI >25. Baseline sleep quality of the partici-
pants was significantly worse than normative values17
(normative value: 25.79; t436¼2.42, p¼0.02), a magnitude
of 0.12 SD.21
Baseline continuous MOS SPI values and odds of sleep
disturbance across quartiles of BMI, rMSSD and VO2peak
are shown in table 2. Sleep quality significantly differed
among quartiles of rMSSD (F3,343¼2.55, p¼0.05), with
the lowest quartile of rMSSD having significantly worse
baseline sleep quality than the other quartiles of rMSSD.
Similarly, each quartile of rMSSD was associated with
lower odds of having significant sleep disturbance at
baseline compared with the lowest quartile of rMSSD.
No differences in MOS SPI values or odds of having
significant sleep disturbance were observed across
quartiles of BMI or VO2peak.
Exercise training adherence, diet and unsupervised activity
Treatment adherence was calculated as the percentage
of exercise energy expenditure achieved compared with
the amount of exercise energy expenditure that was
prescribed. Adherence was similar between exercise
groups (4 KKW: 95.1616.1%, eight KKW: 88.5626.1%,
12 KKW: 92.5620.9%), as previously reported.14
Changes in diet and unsupervised activity have been
previously reported.14 22 Preintervention to post-
intervention changes in energy intake did not differ
between treatment conditions. Pedometer-assessed
unsupervised activity ranged from 4766 to 5067 steps/
Table 1 Baseline participant characteristics
All (N[437) Control (n[92)
Exercise groups
4 KKW (n[151) 8 KKW (n[99) 12 KKW (n[95)
Age, years 57.32 (6.46) 57.14 (5.91) 57.78 (6.53) 57.58 (6.63) 56.47 (6.72)
Education, years 14.03 (2.11) 14.01 (2.12) 13.80 (2.02) 14.37 (2.06) 14.00 (2.28)
Married, n (%) 398 (91) 86 (93) 141 (94) 87 (88) 84 (88)
Ethnicity/race, n (%)
White 278 (64) 58 (63) 92 (61) 60 (61) 68 (72)
AfricaneAmerican 128 (29) 23 (25) 49 (32) 32 (32) 24 (25)
Hispanic/other 31 (7) 11 (12) 10 (7) 7 (7) 3 (3)
Employed, n (%) 304 (70) 62 (67) 105 (70) 67 (68) 70 (74)
Cigarette smoking, n (%) 25 (6) 5 (5) 8 (5) 4 (4) 8 (8)
Medication use, n (%)
Antihypertensive 126 (29) 22 (24) 41 (27) 32 (32) 31 (33)
Hyperlipidaemia 73 (17) 14 (15) 31 (21) 17 (17) 11 (12)
Thyroid 65 (15) 12 (13) 19 (13) 16 (16) 18 (19)
Antidepressant 78 (18) 16 (17) 28 (19) 18 (18) 16 (17)
Hormone replacement therapy 202 (46) 48 (52) 67 (44) 43 (43) 44 (46)
Antianxiety 20 (5) 7 (8) 7 (5) 4 (4) 2 (2)
Sedatives/sleep aids 12 (3) 4 (4) 5 (3) 3 (3) 0 (0)
Energy intake, kcal/day 2277.2 (952.6) 2277.4 (947.9) 2213.1 (941.6) 2290.7 (930.7) 2364.7 (1003.5)
Anthropometrics
Weight, kg 84.46 (11.82) 85.77 (12.43) 83.56 (11.42) 84.74 (12.43) 84.33 (11.24)
Body mass index, kg/m2 31.77 (3.85) 32.29 (3.94) 31.54 (3.80) 31.98 (4.08) 31.44 (3.58)
Cardiorespiratory fitness
Relative VO2peak, ml/kg/min 15.37 (2.92) 15.56 (3.00) 15.44 (3.00) 14.70 (2.49) 15.77 (3.05)
Absolute VO2peak, l/min 1.29 (0.26) 1.33 (0.28) 1.28 (0.24) 1.24 (0.24) 1.32 (0.26)
Heart Rate Variability*
rMSSD, ms 22.83 (11.56) 23.35 (11.01) 23.58 (12.24) 23.25 (11.29) 20.68 (11.19)
Subjective sleep quality
MOS Sleep Problems Index 27.92 (18.40) 28.37 (19.71) 27.03 (17.92) 27.35 (18.10) 29.47 (18.32)
Sleep disturbance, n (%) 200 (46) 38 (41) 65 (43) 49 (49) 48 (51)
Data presented as mean (SD) unless otherwise indicated.
*Samples for rMSSD data were 351, 79, 123, 73 and 76 participants for all, control, 4 KKW, 8 KKW and 12 KKW groups, respectively.
KKW, kilocalories of energy expenditure per kilogram of body weight per week; MOS, Medical Outcomes Study; rMSSD, square root of the
mean of the sum of the squares of differences between adjacent ReR intervals; VO2peak, peak rate of oxygen consumption.
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day at baseline and did not differ between groups.
Compared with baseline, daily steps increased for each
group at month 1 (each p<0.05), with greater steps in
the control group than the three exercise groups (each
p<0.05). However, no differences in daily steps between
the control and exercise groups were observed by
months 5 and 6. Among the exercise groups, daily steps
did not change from months 1 through 6. Therefore, the
results reported here are unlikely to be due to changes
in diet or spontaneous activity outside the exercise
training laboratory.
Changes in sleep quality with exercise training
Changes in sleep quality with exercise training are
depicted in figure 2. A significant effect of the inter-
vention was noted in the full model (F8,428¼17.35,
p<0.001), with treatment group being an independent
predictor of change in continuous MOS SPI score
(F3,428¼2.79, p¼0.04) following control for age, BMI,
HRT use, sleep medication use and baseline MOS SPI
values. Moreover, a significant linear doseeresponse
effect was found for MOS SPI scores across treatment
groups (p¼0.02). When compared against control,
a significantly greater improvement in MOS SPI score
was found for the 12 KKW group (p¼0.02).
The association between sleep disturbance (ie, MOS
SPI >25) at postintervention and treatment is summar-
ised in table 3. Compared with control and following
covariate adjustment, each exercise training group had
lower odds of having significant sleep disturbance
following the intervention, with the odds of having
significant sleep disturbance decreasing while exercise
dose increased (linear trend p¼0.01).
Influences of change in weight, fitness and parasympathetic
tone on sleep
Postintervention changes in body weight, para-
sympathetic tone and cardiorespiratory fitness for the
overall DREW sample have been previously reported.14 19
In the present study’s sample, the magnitude of weight
loss did not differ between treatment groups (control:
1.08 (3.70), 4 KKW: 1.23 (3.43), 8 KKW: 1.60 (3.23),
12 KKW: 1.25 (2.83) kg; F3,433¼0.43, p¼0.73). Cardio-
respiratory fitness improved with exercise training in
a doseedependent manner (control: 0.20 (1.88),
Table 2 Associations between baseline sleep quality and BMI, parasympathetic tone and cardiorespiratory fitness
Variable MOS SPI score (95% CI) OR of MOS SPI >25 (95% CI)
BMI (kg/m2)
Q1: $34.7 27.95 (24.54 to 31.36) 1.00 (Referent)
Q2: 31.7 to <34.7 24.37 (20.92 to 27.82) 0.60 (0.35 to 1.03)
Q3: 28.6 to <31.7 30.48 (27.03 to 33.94) 1.14 (0.67 to 1.96)
Q4: <28.6 28.85 (25.46 to 32.24) 0.98 (0.58 to 1.68)
Linear p 0.26 0.53
rMSSD (ms)
Q1: <15.0 31.77 (27.95 to 35.59) 1.00 (Referent)
Q2: 15.0 to <20.9 24.77 (21.04 to 28.51)* 0.53 (0.29 to 0.97)
Q3: 20.9 to <29.0 25.22 (21.36 to 29.09)* 0.43 (0.23 to 0.81)
Q4: $29.0 26.50 (22.64 to 30.35)* 0.46 (0.25 to 0.86)
Linear p 0.08 0.01
VO2peak (ml/kg/min)
Q1: <13.4 29.55 (25.86 to 33.25) 1.00 (Referent)
Q2: 13.4 to <15.2 28.80 (25.35 to 32.25) 1.22 (0.70 to 2.13)
Q3: 15.2 to <17.0 28.60 (25.05 to 32.15) 1.04 (0.58 to 1.87)
Q4: $17.0 24.91 (21.41 to 28.42) 0.63 (0.34 to 1.14)
Linear p 0.10 0.09
Continuous baseline MOS SPI scores (left panels) and ORs of having significant sleep disturbance at baseline (MOS SPI >25) (right panels)
across quartiles of baseline BMI, rMSSD and VO2peak. All analyses adjusted for age, BMI, sleep medication use and HRT use, except when the
covariate quartile was the independent variable.
*Significant difference (p#0.05) in MOS SPI score compared with quartile 1 (referent group).
BMI, body mass index; MOS, Medical Outcomes Study; Q, quartile; rMSSD, square root of the mean of the sum of the squares of differences
between adjacent ReR intervals; SPI, Sleep Problems Index; VO2peak, peak rate of oxygen consumption.
Figure 2 Change in Medical Outcomes Study (MOS) Sleep
Problems Index (SPI) scores among treatment groups. Data
presented as least-squares means695% CIs. Analyses
adjusted for age, body mass index, sleep medication use,
hormone replacement therapy use and baseline MOS SPI
score. Asterisk indicates difference from control (p¼0.02).
KKW, kilocalories of energy expenditure per kilogram of body
weight per week.
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4 KKW: 0.59 (1.83), 8 KKW: 1.13 (1.54), 12 KKW: 1.42
(1.79) ml/kg/min; F3,433¼15.32, p<0.001). Among those
with usable HRV and sleep data (n¼351), rMSSD
improved in a doseedependent fashion with exercise
training (control: 0.20 (8.45), 4 KKW: 2.72 (9.20), 8
KKW: 3.72 (11.47), 12 KKW: 5.29 (9.51) ms; F3,347¼3.82,
p¼0.01). When added to the model analysing differences
in continuous MOS SPI change among treatment
groups, none of these covariates were significant
(p#0.14), and inclusion of these variables did not alter
the previously noted treatment group differences or
linear doseeresponse effects. When individually added
to logistic regression analyses, none of these covariates
significantly affected the odds of having significant sleep
disturbance at postintervention (table 3). In addition,
when change in MOS SPI was evaluated across quartiles
of change in body weight, rMSSD or VO2peak, no signif-
icant between-group differences were noted (data not
shown). Finally, change in MOS SPI did not correlate
with change in body weight, rMSSD or VO2peak (r<0.03,
p>0.58).
DISCUSSION
The key finding from exploratory analyses of the DREW
randomised controlled trial was that exercise training
significantly improved subjective sleep quality in over-
weight/obese postmenopausal women. Specifically, we
observed a doseeresponse trend for the continuous
MOS SPI values and, perhaps most notably, significantly
reduced odds of having sleep disturbance at post-
intervention with even 50% of the recommended dose
of exercise for adults. Interestingly, the improvements in
sleep quality were not related to changes in body weight,
parasympathetic tone or cardiorespiratory fitness.
Previous research
Previous research with postmenopausal women had
yielded conflicting findings regarding whether exercise
improved sleep.9e12 While suggested by prior studies in
this population,9 11 the present study is the first to
document a doseeresponse relationship between exer-
cise and improved subjective sleep quality. Although
sleep was an exploratory outcome of the DREW study, it
is the largest clinical trial to date that has examined the
relationship between aerobic exercise dose and sleep
quality. Our current findings mirror the overall body of
research indicating that exercise improves sleep, most
prominently in those with existing sleep disturbances.8
Clinical implications
When considering the improvements in continuous
MOS SPI scores following exercise training, the clinical
significance is uncertain. The observation that only
those who exercised at a 12-KKW dose experienced
a significant improvement in sleep quality compared
with control may be viewed as discouraging, as this dose
equated to approximately 190 min/week of moderate-
intensity aerobic exercise14 and many individuals may
not be willing to perform that much exercise to improve
sleep. However, the significant doseeresponse effect
suggests that any dose of exercise should benefit sleep,
albeit with larger effects noted with higher levels of
energy expenditure.
In contrast, the greatly reduced odds of having
significant sleep disturbance following exercise training
suggests that exercise may hold the most promise as
a treatment option for postmenopausal women with
significant sleep disturbance. In particular, even an
exercise dose consisting of 50% of the NIH Consensus
Panel physical activity recommendations significantly
reduced the odds of having a postintervention MOS SPI
>25. This is noteworthy since sleep complaints are
prevalent in postmenopausal women,1 and current
treatment options, such as HRT and hypnotic medica-
tion, have often been found to be only mildly efficacious
at improving sleep quality compared with placebo in
postmenopausal women.6 23
The mechanisms by which exercise may improve
subjective sleep quality in postmenopausal women are
unknown. Although the present study was not specifi-
cally designed to address mechanisms of effect,
secondary analyses focused on changes in three variables
Table 3 Prevalence and odds of significant sleep disturbance (ie, Medical Outcomes Study SPI >25) at postintervention
Prevalence Model 1 Model 2 Model 3 Model 4
n (%) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Control 41 (45) 1.00 (Referent) 1.00 (Referent) 1.00 (Referent) 1.00 (Referent)
4 KKW 46 (31) 0.37 (0.19 to 0.73) 0.37 (0.19 to 0.73) 0.34 (0.19 to 0.73) 0.37 (0.19 to 0.73)
8 KKW 33 (33) 0.36 (0.17 to 0.77) 0.36 (0.17 to 0.77) 0.32 (0.17 to 0.77) 0.36 (0.17 to 0.77)
12 KKW 31 (33) 0.34 (0.16 to 0.72) 0.34 (0.16 to 0.72) 0.28 (0.16 to 0.72) 0.34 (0.16 to 0.72)
Linear trend P 0.01 0.01 0.006 0.02
Weight change e 1.00 (0.93 to 1.08) e e
VO2peak change e e 1.10 (0.95 to 1.26) e
rMSSD change e e e 1.01 (0.98 to 1.04)
Model 1 adjusted for age, BMI, sleep medication use, hormone replacement therapy use and baseline sleep quality (SPI #25, SPI >25); model
2 adjusted for change in body weight in addition to variables included in model 1; model 3 adjusted for change in VO2peak in addition to variables
included in model 1; model 4 adjusted for change in rMSSD in addition to variables included in model 1.
KKW, kilocalories of energy expenditure per kilogram of body weight per week; rMSSD, square root of the mean of the sum of the squares of
differences between adjacent ReR intervals; SPI, Sleep Problems Index; VO2peak, peak rate of oxygen consumption.
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which have been shown to be related to sleep: body
weight, parasympathetic activity and cardiorespiratory
fitness. There is a clear association between obesity and
disturbed sleep,24 and weight loss has been found to
reduce sleep complaints.25 Likewise, poor sleepers have
been found to have impaired sleep HRV,26 and exercise
training has been well documented to improve auto-
nomic function.27 Finally, physical fitness has been
previously associated with sleep quality,28 and greater
improvements in fitness have been associated with better
sleep outcomes in some experimental studies.9 12
Nonetheless, in the present study, changes in body
weight, parasympathetic tone or cardiorespiratory fitness
were not significantly related to changes in sleep,
whether assessed by covariate control, change in sleep
quality across quartiles of change in these variables or
correlations between change in these variables and
change in sleep quality. Although significant improve-
ments were noted for rMSSD and VO2peak following
exercise training in this sample,14 19 the variability asso-
ciated with the sleep measure used in the current study
may have masked any possible associations. The present
study suggests that exercise training can result in
improved sleep quality independent of weight loss,
increased fitness or improved autonomic balance.
Strengths and weaknesses
Strengths of the study include a randomised controlled
design, closely supervised intervention, use of a validated
measure of sleep quality and the largest experimental
sample size to investigate the effects of exercise on sleep.
The study population was another strength, as the
prevalence of disturbed sleep was high. Finally, assess-
ment of variables that are related to sleep quality and
may contribute to improved sleep following exercise
training was another strength of the study.
A limitation of the study is that sleep quality was not
a primary outcome of the original DREW trial. There-
fore, results should be interpreted cautiously. Another
study limitation is that sleep was not objectively assessed
(ie, via wrist actigraphy or polysomnography). Because of
the subjective nature of the outcome and impossibility of
blinding participants to their treatment, improvements
in self-reported sleep quality may have been subject to
expectancy effects, as exercise is commonly believed to
improve sleep quality.7 However, the finding of a signifi-
cant linear trend between exercise dose and improve-
ment in sleep quality would not necessarily be expected.
Moreover, that sleep was not a primary outcome of
interest and part of a wide range of study assessments
further reduces the chance of expectancy or demand
biases. Additionally, there is growing recognition of the
merit of assessing subjective sleep quality.29 For instance,
in contrast with subjective sleep quality, objective sleep
has not been found to be altered across the menopausal
transition.30 Furthermore, impaired subjective sleep
quality is what prompts search for treatment, and recent
evidence suggests that traditional objective sleep
measures might be inadequate for detecting subtle
indicators of disturbed sleep.31 It is also noteworthy that
subjective sleep quality has been associated with
quality of life and physical and mental health in
postmenopausal women.32
A lack of assessment of obstructive sleep apnoea
(OSA) was another limitation. Although OSA is consid-
ered to be a male-dominated sleep disorder, post-
menopausal OSA prevalence is similar between men and
women.33 Moreover, excess weight is the primary cause
of OSA for most adults,34 which would place this over-
weight/obese sample at even higher risk for OSA.
Evidence suggests that exercise, in the absence of more
established treatments or significant weight loss, is
moderately efficacious at reducing OSA severity and
improving sleep.35 However, doseeresponse effects of
exercise on OSA severity are unknown.
Finally, because aerobic activity was the only mode of
exercise studied in the DREW trial, the possible effects of
resistance exercise on sleep quality could not be exam-
ined in this sample. Resistance training has been shown
to improve sleep quality,36 though there has been
minimal work comparing different doses of resistance
exercise on sleep quality.37
Conclusions
In summary, in a sample of overweight/obese post-
menopausal women, exercise training significantly
reduced the odds of having significant sleep disturbance.
These improvements in sleep were independent of the
effects of exercise training on body weight, para-
sympathetic tone or cardiorespiratory fitness. Additional
research with more comprehensive measurement of
sleep is warranted, but exercise training appears to
significantly improve sleep quality in postmenopausal
women.
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